The Republican party yesterday took a major step towards their long-promised goal of repealing Obamacare – but it’s far from clear if they can agree on what should replace it.
During a characteristically bizarre and rambling press conference, Donald Trump yesterday fought back against lurid reports from Russia, but two policies nevertheless emerged as priorities:
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh